{"entity":{"id":"nct07826949","kind":"trial","name":"A Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.","aka":[],"tldr":"A phase 1 trial of SRN-101 run by Nicholas Butowski, not yet recruiting.","summary":"A Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma. is a phase 1 interventional study registered as NCT07826949 by Nicholas Butowski, with 6 participants planned, started 2026-11-15. Conditions recorded: Recurrent High-Grade Gliomas, Brain Neoplasm and Glioma. Interventions recorded: SRN-101, Blood Specimen Collection, Surgical Resection and Magnetic Resonance Imaging (MRI).","status":"planned","asOf":"2026-11-03","links":[{"label":"ClinicalTrials.gov NCT07826949","url":"https://clinicaltrials.gov/study/NCT07826949"}],"tags":["pipeline","ctgov-ingest"],"related":[],"cancers":["brain-tumours"],"sections":[],"technologies":[],"targets":[],"drugs":["srn-101"],"companies":["siren-biotechnology"],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT07826949","phase":"1","setting":"A Phase 1 Window-of-Opportunity Study of SRN-101 Administered Prior to Surgical Resection in Adults With Recurrent High-Grade Glioma.","sponsor":"Nicholas Butowski","enrolled":6,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct07826949/","neighbours":{"cancer":[{"id":"brain-tumours","kind":"cancer","name":"Brain and spinal cord tumours (all types)","route":"/cancers/brain-tumours/"}],"drug":[{"id":"srn-101","kind":"drug","name":"SRN-101","route":"/drugs/srn-101/"}],"company":[{"id":"siren-biotechnology","kind":"company","name":"Siren Biotechnology","route":"/companies/siren-biotechnology/"}]}}